Home
NGNE

NGNE

Neurogene Inc.

as of 12-12-2025 11:17am EST

$21.59

+$0.32

+1.53%

Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Neurogene Inc is a clinical-stage biotechnology company committed to overcoming the limitations of neurological diseases into treatable conditions, by harnessing its proprietary transgene regulation technology, EXACTTM (Expression Attenuation via Construct Tuning). It is building a differentiated product portfolio of genetic medicines for rare neurological diseases with high unmet needs. The drug candidates in the company's product pipeline include NGN-401, which is in development for the treatment of Rett syndrome, using its EXACT platform, and NGN-101, a non-EXACT, conventional gene therapy development candidate for the treatment of CLN5 Batten disease, designed to deliver the CLN5 gene and packaged in an AAV9 capsid.

Chart Type:

Time Range:

Founded:	2003	Country:	United States
Employees:	N/A	City:	NEW YORK
Market Cap:	327.8M	IPO Year:	N/A
Target Price:	$38.50	AVG Volume (30 days):	226.2K
Analyst Decision:	Strong Buy	Number of Analysts:	6
Dividend Yield:	N/A	Dividend Payout Frequency:	N/A
EPS:	-4.12	EPS Growth:	N/A
52 Week Low/High:	$6.88 - $37.27	Next Earning Date:	11-13-2025
Revenue:	N/A	Revenue Growth:	N/A
Revenue Growth (this year):	N/A	Revenue Growth (next year):	N/A

AI-Powered NGNE Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold

Model Accuracy: 69.33%

69.33%

Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

View Full NGNE Forecast & Prediction with Hourly Data

Compare NGNE vs Leading Stocks

See how NGNE stacks up against similar companies in the market

Share on Social Networks:

Tools & Resources

Enhance your trading experience with our free tools

Free NGNE Stock Widget

Embed our interactive stock ticker widget on your website for real-time updates.

Free Tool

Stock Alerts on Telegram

Get instant notifications, market insights, and expert analysis delivered to your phone.

Live Updates

Disclaimer

The information presented on this page, "NGNE Neurogene Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.